AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Assura PLC

Director's Dealing Sep 28, 2015

4924_dirs_2015-09-28_0d1134b7-a79f-4101-a0ac-7a77273d8d2e.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4648A

Assura PLC

28 September 2015

28 September 2015

Assura plc

PDMR Sale of Shares under VCP

Further to the announcement made on 25 September 2015 Assura plc, the leading primary care property investor and developer confirms that Andrew Darke, Paul Carroll, Spencer Kenyon and Carolyn Jones, being persons discharging managerial responsibilities ("PDMRs") (but not directors) in the Company have completed the sale of 750,000, 81,939, 75,308 and 62,799 shares respectively at an average price of 53.73 pence per share.

This notification is made in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

- Ends -

For more information, please contact:

Assura plc Tel: 01925 420660
Orla Ball

Carolyn Jones
Finsbury Tel: 0207 251 3801
Gordon Simpson

Notes to Editors

Assura is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington and listed on the London Stock Exchange, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2015, Assura's property portfolio was valued at £931 million.

Further information is available at www.assuraplc.com .

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSEAKNPALXSEFF

Talk to a Data Expert

Have a question? We'll get back to you promptly.